Back to top
more

ISHARES US PHARMACEUTICALS ETF: (IHE)

(Delayed Data from AMEX) As of Jul 26, 2016 03:59 PM ET

 Add to portfolio

$152.93 USD

152.93
8,210

-0.34 (-0.22%)

Volume: 8,210

Zacks ETF Rank [?]: 3 - Hold     3    

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Quote Details

Previous Close 153.27
Open 152.85
Bid 152.12
Ask 155.39
Day Low-High 152.60-153.74
52wk Low-High 113.55-182.85
Volume 8,210
NAV (month end) 144.60
Premium (+)/Discount (-) (month end)+8.67

Zacks Premium Research for IHE

Zacks ETF Rank [?] Hold 3
ETF Risk [?] Med
ETF Research Report

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Expense Ratio

Expense Ratio 0.43%
Dividend (Yield) $1.47 (0.96%)
Issuer BLACKROCK

Benchmark for IHE

DOW JONES US SELECT PHARMACEUTICAL INDEX

This Index is a subset of the Dow Jones U.S. Pharmaceuticals and Biotechnology Index which is a free-float adjusted market capitalization-weighted index.The Index measures the performance of the pharmaceuticals sector of the U.S. equity market.The Index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.

Fund Summary for IHE

ISHARES US PHARMACEUTICALS ETF

The iShares U.S. Pharmaceuticals ETF seeks investment results that correspond generally to the price and yield performance of Dow Jones U.S. Select Pharmaceuticals Index